Perioperative Considerations for Patients on GLP1 Agonists

GlP-1 receptor agonists are a class of medications that are becoming increasingly popular. Large trials have shown that their use provides reliable weight loss in obese patients and improved glycemic control in diabetic patients . Its use also has broader implications for overall metabolic health and has been shown to improve cardiovascular outcomes in high-risk populations. Glucagon-like ...

Evaluation and risk assessment of patients taking GLP-1 receptor agonists and undergoing anesthesia represent a new challenge for anesthesia providers.
New Multi

Most patients should continue taking their glucagon-like peptide-1 ( GLP-1 ) receptor agonists before elective surgery, suggests new clinical guidance released by the American Society of Anesthesiologists (ASA), American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and the Society of ...
The perioperative management of patients using glucagon-like peptide 1 receptor agonists remains a topic of debate. While several multisociety statements have been published recently, the recommendations vary significantly in terms of medication management and preoperative fasting protocols for these patients . This document represents a multidisciplinary consensus statement led by the Society ...

Perioperative management of patients taking glucagon
Summary The perioperative management of patients using glucagon-like peptide 1 receptor agonists remains a topic of debate. While several multisociety statements have been published recently, the recommendations vary significantly in terms of medication management and preoperative fasting protocols for these patients .
This flowchart outlines the steps for managing patients on GLP-1 receptor agonists during the perioperative period, including risk assessment, preoperative preparation, anesthesia induction, and postoperative monitoring.

Multisociety Clinical Practice Guidance for the Safe Use of Glucagon ...
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have revolutionized the care of patients with metabolic disease due in part to the agonists' unique combination of effects, including decreasing hyperglycemia and enhancement of satiety.1,2 GLP-1 , a naturally secreted polypeptide, acts on the GLP-1R in multiple organs, including the pancreas, brain, heart, kidney, and stomach.3 In the ...
Patients taking glucagon-like peptide-1 receptor agonists and dual glucose-dependent insulinotropic peptide receptor agonists should: continue these drugs before surgery; have full risk assessment and stratification; and receive peri-operative techniques that may mitigate risk of pulmonary aspiration before, during and after sedation or general ...

PDF American Society of Anesthesiologists Consensus
American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 ( GLP-1 ) Receptor Agonists Update: In October 2024, ASA issued an Affirmation of Value for a more recent, multi








American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 ( GLP-1 ) Receptor Agonists Update: In October 2024, ASA issued an Affirmation of Value for a more recent, multi-society guidance GLP-1 document. Read more ...